Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Authors
Taha Merghoub (ORCID: https://orcid.org/0000-0002-1518-5111)
Xuejun Chen
Dana B. Cardin (ORCID: https://orcid.org/0000-0002-0269-9615)
Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar et al.
Topics
Neuroblastoma Research and Treatments
article
Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar, Omid Hamid, Patricia LoRusso, James J. Harding, Roberta Zappasodi, Zhiwan Dong, F. Stephen Hodi, Feng Zhou, Manfred Velden, John E. Janik